Objective: To contribute to the debate, discussed in an earlier issue, regarding the role of adrenoceptors in the genesis of early, coronary artery occlusion-induced ventricular arrhythmias. Methods: Mongrel dogs anaesthetised with chloralose and urethane were group of dogs noradrenaline was infused intravenously in a dose of 1 and then 2 mg kg min over a period of 60 min, 24 h prior to coronary artery occlusion. Haemodynamic and coronary blood flow changes, as well as changes in the epicardial ST-segment and in the degree of inhomogeneity were continuously recorded. Ventricular arrhythmias were evaluated as ventricular premature beats (VPBs), tachycardiac (VT) episodes and the incidences of VT and ventricular fibrillation (VF) during occlusion and following reperfusion. Results: Compared to the controls, NA markedly reduced the severity of ventricular arrhythmias resulted from coronary artery occlusion and increased survival (to 40%) following reperfusion; there were no survivors in the control group. Noradrenaline released endogenously following guanethidine administration was also protective. Protection was also seen, although to a lesser extent with intracoronary PHE (occlusion VF 20% cp 80% in controls; survival 42%). In contrast, ISO enhanced arrhythmia severity; five out of seven dogs infused with ISO fibrillated within 10 min of the commencement of occlusion and no dog survived reperfusion. Other indices of ischaemia severity (epicardial ST-segment and inhomogeneity) were also reduced by NA and by PHE. NA, infused 24 h prior to occlusion was also protective against ischaemia and reperfusion-induced arrhythmias and ischaemia-induced changes in inhomogeneity. Conclusion: We conclude that exogenously administered NA, or released endogenously by chemical means, reduces the severity of ischaemia and reperfusion-induced ventricular arrhythmias and that this is mediated by a-adrenoceptors, perhaps through presynaptic inhibition of local NA release or by a 'preconditioning' effect presumably mediated by PKC.
is occluded in the presence of exogenous noradrenaline (or renaline, isoprenaline or phenylephrine. Epicardial STadrenaline), either in vivo [7] [8] [9] or in isolated perfused segment changes, and the degree of inhomogeneity of hearts [10] , there are reductions in all parameters of activation, were measured from the left ventricular wall arrhythmia severity. The protection in vivo does not appear distal to the proposed coronary artery occlusion using to be due to an increase in perfusion pressure since the unipolar electrodes and a composite electrode previously protection was apparent in studies when this did not occur described [23] . This composite electrode gives a summa- [7] or when it was prevented [9] .
rised recording of R-waves from 30 epicardial measuring A protective role of the sympathetic nervous system, points. When the myocardium is adequately perfused and mainly through a-adrenoceptor stimulation, has also been oxygenated all sites are activated almost simultaneously, evoked to explain the effects of ischaemic preconditioning resulting in a single large spike. Following occlusion, (reduction in myocardial ischaemic damage; enhanced however, widening and fractionation of the summarised recovery of contraction after a period of ischaemia and R-wave occurs indicating that adjacent fibres are not reperfusion). This has been shown in a variety of species, simultaneously activated because of inhomogeneity of in rats [10] [11] [12] [13] , in rabbits [14] [15] [16] and in some [17] conduction. We express this as the greatest delay in although not all [18] , studies in dogs. Further, precondiactivation (in milliseconds) within the ischaemic area tioning does not limit infarct size in hearts where there are underneath the electrodes. no measurable cardiac noradrenaline levels In some of the experiments blood flow in the left [11, 19, 20 ].There seems little doubt then that noradrenaline circumflex coronary artery (LCX) was measured with a can mimic the infarct limiting effects of preconditioning, 2.0-mm electromagnetic flow probe and a Statham SP2202 most likely through activation of protein kinase C [15, 21] . flow meter. Blood flow was also measured on the (ocThe situation, however, regarding arrhythmias is less clear cluded) left anterior descending coronary artery (LAD) by and has not been examined in large animal models. We means of a Doppler flow probe (Triton Technology, USA) now describe, in a well defined canine model, the effects positioned distal to the proposed occlusion site. These of noradrenaline, and also of the more selective a-and parameters, together with a limb lead electrocardiogram, b-adrenoceptor agonists phenylephrine and isoprenaline, systemic arterial pressure (S, systolic; D, diastolic; mean, infused directly into a side branch of a coronary artery, on MABP) and left ventricular (LV) systolic (S) and endthose arrhythmias that result from acute coronary artery diastolic (ED) pressures (Statham P23XL transducers) and occlusion and reperfusion. A preliminary account of the LVdP/dt were recorded on an eight-channel Medicor R81 initial studies with intracoronary noradrenaline was given recorder. in 1994 [22] .
.2. Assessment of ventricular arrhythmias

. Methods
Ventricular arrhythmias during ischaemia and reperfu-2 .1. Animals and experimental design sion were analysed as outlined previously [23] . This analysis is based on the suggestions made at the 'Lambeth Mongrel dogs, of either sex, and with a body weight in Conventions' [24] . No distinction was made between excess of 17 kg (mean 27.562.0 kg) were anaesthetised couplets and salvos, which were included as single venwith a mixture of chloralose and urethane (60 and 200 mg tricular ectopic (premature) beats, and we defined ventricu-21 kg i.v., respectively). They were ventilated with room lar tachycardia (VT) as a run of four or more ectopics at a 21 air using a Harvard respirator at a rate (usually 13 min ) rate faster than the resting sinus rate. and volume sufficient to maintain arterial blood gases and
We also estimated the number of episodes of VT during pH within normal limits [23] . Body temperature was coronary artery occlusion, and the incidences of VT and measured either from the oesophagus or from the rectum ventricular fibrillation (VF) both during occlusion and on and maintained by a heating pad between 36.7 and 37.4 8C.
reperfusion at the end of a 25-min occlusion period. The origin and upkeep of these dogs were in accord with Survival indicates those dogs which were in sinus rhythm Hungarian law (XXVIII, Chapter IV, Paragraph 31) regard-5 min following reperfusion after a 25-min occlusion ing large experimental animals which comply with those of period. In some experiments using noradrenaline, where the European Commission as described in the regulations dogs survived the initial occlusion period, the animals dated 16 December 1991.
were left for a further 1-2 h and the occlusion repeated in A thoracotomy was performed at the fifth intercostal the presence of an infusion of normal saline given at the space and the anterior descending branch of the left same volume and rate. coronary artery (LAD) prepared for occlusion just proximAt the end of each experiment, the area at risk was al to the first main diagonal branch. A smaller branch of assessed by infusing patent blue V dye into the occluded this artery, proximal to the proposed site of occlusion, was artery at a pressure equivalent to that of mean arterial catheterised for the intracoronary infusion of saline, noradblood pressure. The area at risk was expressed as a [26] that in this dose guanethidine initially releases to determine whether or not there were significant haemocatecholamines from sympathetic nerve endings and dynamic differences between the groups. Ventricular prefrom cromaffin tissue, a phenomenon sometimes remature beats were compared by using the Mann-Whitney ferred to as 'sympathomimesis', before eventually rank sum test, and the incidences of VT and VF, and depleting tissue catecholamines and exerting an adrensurvival from the combined ischaemia and reperfusion ergic neurone blocking effect. insult, were compared using the Fisher exact test. Differences between groups were considered significant when P was less than 0.05.
. Results
.4.
Infusions of noradrenaline, phenylephrine, 3 .1. Haemodynamic effects of local intracoronary isoprenaline, and normal saline infusions of noradrenaline and of subsequent coronary artery occlusion There were six experimental groups:
The haemodynamic changes resulting from norad-(i) Noradrenaline. In 13 dogs noradrenaline was infused renaline administration are outlined in Table 1 . There were 21 21 in a dose of 100 ng kg min and at a rate of 0.5 ml significant increases in arterial blood pressure, in left 21 min into the side branch of the LAD coronary artery ventricular systolic pressure and in LV/ dP/dt ; blood max commencing 10 min prior to coronary artery occlusion flow in the circumflex branch of the coronary artery was and then throughout the occlusion period.
significantly increased but there was no change in resist-(ii) Phenylephrine. This was given in a dose of 200 ng ance in this vascular bed (Table 1) . Similarly, blood flow 21 21 kg min by intracoronary infusion and at a rate of was also increased in the vessel (LAD) in which the (iii) Isoprenaline. Isoprenaline (12.5 ng kg min ) was There were no significant changes in LVEDP, in epicardial administered by intracoronary infusion at a rate of 0.5 ST-segment elevation or in the inhomogeneity of electrical 21 ml min to a group of seven dogs again commencing activation during the infusion. 10 min prior to coronary artery occlusion and throughThe haemodynamic effects of subsequent coronary out the occlusion period.
artery occlusion in these dogs are shown in Table 2 and The chosen doses of phenylephrine and isoprenaline were similar to those obtained in the control saline infused were intended to give either similar increases in blood dogs (see below). These changes, which were maximum at pressure to those resulting from noradrenaline infusion 3-5 min, included decreases in arterial blood pressure and (phenylephrine), or similar increases in positive LVdP/ in L VdP/ dt and substantial increases in LVEDP and in max dt to those resulting from noradrenaline infusion left circumflex coronary flow ('compensatory vasodilat-(isoprenaline).
ation').
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(iv) In the controls normal saline, at a rate of 0.5 ml min was infused into a side branch of the coronary artery 3 .2. Haemodynamic effects of phenylephrine and of for a period of 10 min and then throughout the 25-min subsequent coronary artery occlusion coronary artery occlusion. (v) Because of evidence in rats [10] that noradrenaline can
The results are shown in Tables 1 and 2 . The dose of induce a delayed protection of the myocardium against phenylephrine was chosen in order to give approximately early occlusion-induced ventricular arrhythmias, a similar increases in blood pressure to those already deseparate series of experiments was carried out in 13 scribed for noradrenaline (see Table 1 ). The slight indogs using intravenous noradrenaline at rates of 1 mg creases in LVdP/dt were not significant and probably max 21 21 21 21 kg min (for 30 min) and then of 2 mg kg min reflect changes in afterload. Phenylephrine, in this dose, (for a further 30 min). Blood pressure and heart rate did not induce changes in blood flow or resistance in either (mmHg ml min )
Values shown are those at baseline (pre-infusion) and the change at the end of 10 min, i.e., immediately prior to coronary artery occlusion. *P,0.05 cp baseline; **P,0.05 cp noradrenaline.
the circumflex ( in two dogs this was largely achieved. This dose of at a rate of 0.5 ml min , by the intracoronary route (Table isoprenaline decreased diastolic arterial blood pressure (by 1) and the haemodynamic effects of coronary artery a mean of 1964 mmHg) and increased heart rate (by a occlusion (Table 2) were similar to those obtained previ-
mean of 11962 beats min ). It also resulted in a marked ously in several control groups (e.g., Refs. [23, 25] ) and to (of 2463 ml min ).
.5. Haemodynamic effects of intravenous noradrenaline given 24 h prior to coronary artery occlusion
These included marked increases in arterial blood pressure (of 9967 mmHg systolic and 4065 mmHg diastolic from pre-infusion levels of 15566 and 12665 mmHg, respectively) which were maximal after 5 min. Heart rate responses were variable; in some dogs there were marked decreases in heart rate (by as much as 50 21 beats min ) whilst in others there were slight increases
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(of up to 30 beats min ). The mean change was in-21 significant (16611 beats min ). When the infusion was switched off at the end of 1 h there was a substantial post-infusion hypotension to levels, after 5 min, of 11568 mmHg (systolic) and 8767 mmHg (diastolic). ticularly marked were the reductions in the incidences of VT during occlusion and in VF during occlusion and reperfusion. In four of the five dogs that survived reperfuthis was not significantly different to that in the control, sion at the end of the occlusion period, saline was saline infused group (total number of VPBs during the substituted for noradrenaline and infused for a period of 1 25-min occlusion period of 291691 cp 430672 in the h before the coronary artery was re-occluded. There were controls; ns). Although most (80%) of the dogs had more arrhythmias in these dogs during the second (saline) periods of VT only two of the 10 dogs fibrillated during infusion than during the first (noradrenaline) infusion. For occlusion and four survived the combined ischaemiaexample there were only 0, 4, 4 and 61 ectopic beats in reperfusion insult. These results are also summarised in these four dogs during the noradrenaline infusion (mean Fig. 1 . 1766) but 151, 135, 308 and VF, respectively, during the subsequent saline infusion (mean 1986116; P,0.05).
.6. Effects of noradrenaline, phenylephrine and isoprenaline on arrhythmias resulting from coronary artery occlusion and reperfusion
3 .6.3. Effects of intracoronary isoprenaline These results are illustrated in Fig. 2 .
Ventricular ectopic activity occurred in each of the seven dogs during the isoprenaline infusion prior to occlusion 3 .6.2. Effects of intracoronary phenylephrine (mean of 2267 ventricular ectopic beats) and two of these There were only occasional ventricular ectopic beats had brief periods of VT. Five of the seven dogs infused during the 10-min infusion of phenylephrine prior to the with isoprenaline fibrillated within 10 min of the comocclusion. However, there was substantial ventricular mencement of occlusion (mean time to VF 5.461.3 min) ectopic activity during the occlusion period in these dogs; and the remaining two fibrillated during reperfusion. These The number of VPBs, the incidence and number of episodes of VT, the incidence of VF during occlusion and reperfusion, and survival from the combined ischaemia-reperfusion insult in dogs given noradrenaline by intracoronary infusion during the initial (25 min) occlusion (filled histograms) and then given saline, by the same route, 1 h later. There was marked protection by noradrenaline during the first occlusion which was less marked when saline was substituted for noradrenaline 1 h later. The control data are shown in Fig. 1 .
two dogs had marked ectopic activity during the occlusion nounced when phenylephrine was infused during the period (Fig. 1) . occlusion compared to controls. Because most of the dogs infused with isoprenaline fibrillated within 5 min of the 3 .7. Effects of noradrenaline and phenylephrine on occlusion, and because even prior to this there was epicardial ST-segment elevation and on changes in substantial ventricular ectopic activity, no calculations inhomogeneity of electrical activation within the were possible in these dogs of changes in the epicardial ischaemic area ST-segment, or in the degree of inhomogeneity.
.7.1. Effects of intracoronary noradrenaline .8. Area at risk in controls, and in dogs infused with
The mean results for all 13 dogs on epicardial STnoradrenaline, phenylephrine and isoprenaline segment changes are illustrated in Fig. 3 . In the four dogs that were re-occluded and in which saline was substituted There were no significant differences between the for noradrenaline, the ST-segment elevation was more groups either in body weight (26.461.2 kg in the controls, (Fig. 4) than during the initial occlusion in the presence of 27.562.0 kg in the noradrenaline group, 26.061.8 kg in noradrenaline (e.g., 22 .362.3 cp 14.964.3 mV at 5 min; the phenylephrine group and 27.961.8 kg in the iso-P,0.05).
prenaline group) or in the risk area (36.561.4% in the Changes in the inhomogeneity of electrical activation controls; 39.361.6% in the noradrenaline group; are also illustrated in Fig. 3 . As with the epicardial ST-42.262.6% for phenylephrine and 36.862.1% for isosegment changes, these were less marked when the corprenaline). onary artery was occluded in the presence of noradrenaline. In the four dogs in which the artery was re-3 .9. Delayed cardioprotection by noradrenaline infused occluded, and when saline was given in place of noradintravenously 24 h previously renaline, changes in inhomogeneity were again more marked during the second occlusion (Fig. 4; e. g., an
The maximum changes in blood pressure and heart rate increase of 183620 cp 68620 ms; P,0.05 at 5 min).
that occurred during the intravenous infusion of norad- 21 21 renaline (1 and then 2.0 mg kg min ) have been given 3 .7.2. Effect of intracoronary phenylephrine and of above. There were ventricular extrasystoles during the isoprenaline infusions and, occasionally, brief periods of VT. These The results for phenylephrine are also given in Fig. 3 . usually reverted to sinus rhythm during the infusion As with noradrenaline, ischaemic changes were less properiod. One dog died during administration of the higher During the first occlusion noradrenaline was infused by the intracoronary differences at each measured time point between controls and dogs given route (closed circles); during the second occlusion saline was infused either noradrenaline or phenylephrine are significant at a level of P,0.05.
(open circles) by the same route. The reduction in ischaemia severity during the noradrenaline infusion was attenuated when saline was substituted during the second occlusion 1 h later. Data from control dogs is shown in Fig. 3 . The differences at each measured time point between the dogs given noradrenaline and saline 1 h later, are significant at a level dose of noradrenaline and two further dogs died overnight.
of P,0.05.
Next day the remaining 10 dogs were subjected to coronary artery occlusion as outlined above; one of these was later omitted from the series because the area at risk exceeded 50%. The area at risk in the remaining nine dogs 3 .10. Effect of guanethidine was 42.761.9%.
Although arrhythmias in the noradrenaline-treated dogs The administration of guanethidine resulted in marked tended to be less than those in the controls (Fig. 5) , the sympathomimetic effects which were prolonged, in some only significant changes were reductions in the number of dogs persisting for up to the time when the coronary artery ectopic beats, in the incidence of VF during coronary was occluded 1 h later. The maximum responses occurred artery occlusion, in epicardial ST-segment elevation and in within 5-10 min and were characterised by substantial the degree of inhomogeneity during ischaemia (Fig. 6) .
increases in blood pressure (of 116618 and 6469 mmHg Although the control group was not strictly comparable, from preinjection levels of 14163 mmHg systolic and our previous studies have shown that catheterisation and 9664 diastolic; P,0.01), in heart rate (an increase of 21 re-anaesthesia have no effect on arrhythmias, or on is-91611 beats min from a basal level of 14066 beats activity following the injection (of from three to 282 severity of arrhythmias that result from coronary artery ventricular premature beats; mean 61634); in one of these occlusion; this protection fades within 1 h. Protection is dogs there were several episodes of VT and in another also seen, albeit to a lesser extent, with intracoronary sudden VF occurred 10 min after the administration; just phenylephrine; isoprenaline, in contrast, enhances arrhythprior to this the arterial pressure in this dog was 290 / 190 mia severity. Other indices of ischaemia severity such as 21 mmHg and the heart rate 230 beats min . changes in the degree of inhomogeneity of activation and When the coronary artery was occluded there were ST-segment changes, recorded from epicardial electrodes, fewer VPBs (181647, i.e., less than 8 VPBs / min) during were also reduced by noradrenaline and by phenylephrine the 25-min ischaemic period than in the controls and only but not by isoprenaline. one of the seven dogs (14%; P,0.05) fibrillated during the In previous studies implicating a-adrenoceptor stimulaocclusion period. Further, other ischaemic changes were tion as a mechanism in reducing myocardial ischaemic less than in the control group (e.g., degree of inhomodamage and stunning [10, 11, [13] [14] [15] [16] [17] , and in enhancing the geneity at 5 min 117610 ms compared to 210610 ms in recovery of contractile force following reperfusion, use the controls; P,0.05). Survival from reperfusion was also was made of a variety of drugs that block the effects of higher than in the controls (50 vs. 0%; P,0.05) despite noradrenaline on these receptors. The facts that several the fact that the area at risk (43.661.6%) was rather such drugs (prazosin, chloroethylclonidine, phentolamine greater than in the controls (36.561.4%). In two of the and phenoxybenzamine) antagonised the beneficial effects dogs that survived reperfusion at the end of the 25-min of noradrenaline in these models [11, [13] [14] [15] [29] [30] [31] , and occlusion period, the same coronary artery was re-octhat protection was also observed with the rather more cluded, again for 25 min, 2 h later, i.e., at a time when selective a-adrenoceptor agonist phenylephrine neither the sympathomimetic effects of guanethidine, or [11, 13, 15, 16] argue strongly for a role of a-adrenoceptor the preconditioning effects of infused noradrenaline, were stimulation in mediating these particular protective effects. no longer apparent. These dogs had fewer VPBs (35 and We could not use the first of these approaches because 76, respectively) during the second occlusion and both of these drugs, especially prazosin, are themselves powerfully these dogs survived reperfusion at the end of the ischaemic antiarrhythmic [9, 32, 33] . In the present study, and in a period.
dose that resulted in a similar pressor effect, phenylephrine was less effective than noradrenaline in reducing the incidence of VT and the number of ventricular ectopic 4 . Discussion beats, although VF during occlusion was similarly reduced and survival from the combined occlusion-reperfusion These results show that the local intracoronary adminisinsult was increased. Our conclusion is that it is a-adrenotration of noradrenaline to the canine heart reduces the ceptor stimulation that is responsible for this suppression (1) The antiarrhythmic effect may result from a reduction in the severity of ischaemia, as suggested by the less marked changes in epicardial ST-segment elevation and in the inhomogeneity of conduction. The fact that other studies have demonstrated a reduction in ultrastructural ischaemic damage [14] [15] [16] and an enhanced recovery of contractile function following reperfusion [11, 13] , would suggest that this is certainly a factor in suppressing ventricular ectopic activity during ischaemia. That the reduction in the severity of ischaemia is the result, rather than the cause, of the less pronounced ectopic activity seems less likely, despite the fact that coronary blood flow to the ischaemic region is compromised during such activity, as shown by the marked decrease in peripheral pressure especially during periods of VT [34] . However, one might expect the severity of ischaemia to be increased, rather than decreased, by noradrenaline administration since myocardial contractility, at least as assessed by alterations in LVdP/ dt , is increased and the cormax onary blood flow elevation seems too small to solely explain the marked changes in epicardial ST-segment elevation or in conduction delay. (2) Some authors [29, 35] have suggested that a-adrenoceptor-mediated noradrenaline protection involves adenosine receptor activation. The evidence for this is that PD 115,199, which antagonises the effects of adenosine on most adenosine receptors, also abolishes the protection that results from the administration of tyramine, which induces noradrenaline release from cardiac sympathetic nerves. Adenosine involvement is not now thought to be critical [15] , although it could [36]. (3) In the original study of Regan et al. [7] , in which of those life-threatening ventricular arrhythmias that nornoradrenaline was infused intravenously 15 min after mally result in the first few minutes following coronary the onset of myocardial ischaemia induced by thromartery occlusion. This is supported by the failure, as bus formation in the LAD, the reduction in arrhythexpected, of isoprenaline to beneficially modify these mias that occurred over the next hour of ischaemia arrhythmias; it could thus hardly be the b-adrenoceptor was associated with a reversal of the potassium loss stimulant property of noradrenaline that is responsible for that normally occurs during ischaemia, and this deits ability to protect.
spite the persistent production of lactate. It was of interest that, in the present study, protection (4) The antiarrhythmic effect of exogenous noradrenaline was also seen following the administration of might be due to modulation of neuronal noradrenaline guanethidine. Initially this leads to substantial noradrelease by an action on presynaptic a-adrenoceptors renaline release with resultant, very marked, sympathomisituated on the terminal endings of cardiac sympametic effects. We suggest that this endogenous release of thetic nerves. Inhibition of neuronal noradrenaline catecholamines from stores throughout the body also release probably explains the cardioprotective effects preconditions the heart against the consequences of a of dopamine receptor agonists such as Z1046 [25] , subsequent coronary artery occlusion. Presumably, this is and of adrenergic neurone blocking drugs such as also mediated through an a-adrenoceptor mechanism.
guanethidine, several hours after administration (see There are several possible mechanisms involved in aSection 3.10). Such a presynaptic effect of exogenous adrenoceptor mediated cardioprotection: noradrenaline could explain why, whereas this can mimic ischaemic preconditioning, sympathetic nerve ised, ventilated rats 24 h after the intraperitoneal adminisstimulation, for example via the stellate ganglion, is tration of noradrenaline, there was a marked reduction in ineffective in this respect. The explanations offered arrhythmia severity [10] similar in degree to that observed that 'insufficient noradrenaline is released to trigger in the present study. In the experiments in rats this was 1 the protection' or that 'dogs differ fundamentally from accompanied by the preservation of sarcolemmal Na / 1 rabbits' [15] seem improbable. We know of no in vivo K -ATPase, which is normally decreased under conditions studies designed to explore the possibility that aof ischaemia. In summary, we show that exogenously adrenoceptor agonists given exogenously inhibit the administered, or endogenously released noradrenaline, release of endogenous noradrenaline from cardiac reduce the severity of those arrhythmias that result from nerve endings, by loading these neurones, for examcoronary artery occlusion and reperfusion, that this is 3 ple, with [ H]noradrenaline. We did take up a sugmediated by a-adrenoceptors and that this protection is gestion to examine the role of presynaptic a -adrenoboth acute (lasting about 1 h) and delayed. This is in 2 ceptors in the cardioprotective effects of exogenous accord with other studies, reviewed in Section 1, that noradrenaline by attempting to selectively block these catecholamines can protect the heart against brief periods receptors with yohimbine using a dose (0.03 mg of ischaemia, as shown by a reduced degree of ischaemic 21 kg ) that has been used to study the role of these damage (infarct size) and an enhanced recovery of contracreceptors in the release of cardiac noradrenaline tile force following reperfusion. during exercise [37] . However, in this study [37] even in the resting state yohimbine itself resulted in a 3-fold elevation of noradrenaline in the coronary sinus A cknowledgements and, perhaps as a result of this, yohimbine in our hands itself reduced arrhythmia severity. It was thus Leverhulme Trust Emeritus Fellowship. (5) Stimulation of a-adrenoceptors is one of the principal activating pathways for protein kinase C [38] and this pathway also plays a major role in mediating some of R eferences the manifestations of ischaemic preconditioning, such as the reduction in infarct size (reviewed in Ref. [39] induced nitric oxide synthase [40] . There is some
